Results 171 to 180 of about 78,708 (218)
Establishing RTS,S/AS01 as a benchmark for comparison to next-generation malaria vaccines in a mouse model. [PDF]
NPJ VaccinesLocke E +10 more
europepmc +1 more source
The selective pressure induced by malaria vaccines onPlasmodium falciparum
Masserey T +5 more
europepmc +1 more source
Meditsinskaia parazitologiia i parazitarnye bolezni, 2013 A M, Baranova, T M, Guzeeva
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Infectious Disease Clinics of North America, 1990
Malaria continues to be a major worldwide problem. Recent advances in our understanding of the parasite and the immune response to malarial infections has resulted in major advances in the progress toward an effective malaria vaccine. Owing to the complexity of the parasite's life cycle, an effective vaccine will most assuredly contain components ...
Deirdre Herrington +3 more
+6 more sources
Malaria continues to be a major worldwide problem. Recent advances in our understanding of the parasite and the immune response to malarial infections has resulted in major advances in the progress toward an effective malaria vaccine. Owing to the complexity of the parasite's life cycle, an effective vaccine will most assuredly contain components ...
Deirdre Herrington +3 more
+6 more sources
Expert Opinion on Therapeutic Patents, 2023
Eradication of malaria remains one of the main aims of medicine. Despite progress in malaria treatment, mortality rate remains high, especially in the poorest parts of the world. Therefore, prevention through vaccines is fundamental and recent approval of the first effective vaccine reinforced this assumption.
Michael Quagliata +2 more
openaire +4 more sources
Eradication of malaria remains one of the main aims of medicine. Despite progress in malaria treatment, mortality rate remains high, especially in the poorest parts of the world. Therefore, prevention through vaccines is fundamental and recent approval of the first effective vaccine reinforced this assumption.
Michael Quagliata +2 more
openaire +4 more sources
Current Biology, 1992
The development of an effective malaria vaccine is a feasible goal. Most of the vaccines being developed today are subunit vaccines derived from selected parasite antigens or their immunologically active fragments. The precise characterization of protective immune responses against Plasmodium parasites remains a fundamental part of present research ...
M F, Good, A, Saul, P M, Graves
openaire +4 more sources
The development of an effective malaria vaccine is a feasible goal. Most of the vaccines being developed today are subunit vaccines derived from selected parasite antigens or their immunologically active fragments. The precise characterization of protective immune responses against Plasmodium parasites remains a fundamental part of present research ...
M F, Good, A, Saul, P M, Graves
openaire +4 more sources
Experientia, 1991
Among infectious diseases caused by protozoa, malaria is still the greatest killer of children. Mortality in adults living in endemic areas is significantly lower because they frequently acquire partial or complete immunity to the major pathogen, Plasmodium falciparum.
openaire +4 more sources
Among infectious diseases caused by protozoa, malaria is still the greatest killer of children. Mortality in adults living in endemic areas is significantly lower because they frequently acquire partial or complete immunity to the major pathogen, Plasmodium falciparum.
openaire +4 more sources
Parasitology Today, 2000
Although the possibility of a live attenuated malaria vaccine has been considered, current malaria vaccine development activities are dominated by attempts to develop a subunit vaccine. Hence, it is entirely appropriate that a session of the Molecular Approaches to Malaria conference, Lorne, Australia, 2-5 February 2000, was devoted to vaccine ...
R F, Anders, A, Saul
openaire +2 more sources
Although the possibility of a live attenuated malaria vaccine has been considered, current malaria vaccine development activities are dominated by attempts to develop a subunit vaccine. Hence, it is entirely appropriate that a session of the Molecular Approaches to Malaria conference, Lorne, Australia, 2-5 February 2000, was devoted to vaccine ...
R F, Anders, A, Saul
openaire +2 more sources
Journal of Clinical Immunology, 1996
Significant progress has been made in the development of the malaria vaccine during the last 20 years. Ninety percent of the 300-500 million clinical cases of malaria per year worldwide occur in Africa. Thus, research must be directed toward the 1 million African children under 5 years of age who die every year of malaria.
R, Amador, M E, Patarroyo
openaire +2 more sources
Significant progress has been made in the development of the malaria vaccine during the last 20 years. Ninety percent of the 300-500 million clinical cases of malaria per year worldwide occur in Africa. Thus, research must be directed toward the 1 million African children under 5 years of age who die every year of malaria.
R, Amador, M E, Patarroyo
openaire +2 more sources